Tripos International is the global leader in accelerating medicines with biosimulation. Since 2014, our customers have received an impressive 90% of new drug approvals by the FDA, thanks to our innovative software and tech-enabled services. We offer a range of products and services that support the entire drug development process.

Our Biosimulation software utilizes quantitative drug development, also known as modeling and simulation, to optimize the discovery and design-make-test-analyze cycles. With our Data Science solutions, you can visualize and analyze both clinical and non-clinical data, facilitating informed decision-making. We also specialize in Regulatory services, offering tools to increase efficiency in regulatory preparation and submission processes.

Our Market Access solutions help overcome the challenges of demonstrating and delivering value effectively. Furthermore, our Discovery Informatics products improve research data utilization and optimize drug design. With our advanced Deep Learning Analytics and AI tools, we bring cutting-edge technology to the field of drug development.

Our software platforms, such as Phoenix™ PK/PD and D360™ Scientific Informatics Software, are industry gold-standards, providing user-friendly and powerful analysis capabilities. When you choose Tripos International, you gain access to our expertise, commitment, and dedication to accelerating medicines and advancing the field of biosimulation